MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
291.00%
Quick Ratio
240.53%
Cash Ratio
126.99%
Debt to Asset Ratio
60.03%
Unit: Thousand (K) dollars
Assets Breakdown
    • Intangible assets, net
    • Cash and cash equivalents
    • Accounts receivable, net
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Convertible notes, net
    • Accounts payable
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
360,212
311,176
285,585
262,610
Restricted cash
35
36
36
36
Accounts receivable, net
274,469
255,432
281,082
252,617
Inventories
143,149
143,468
143,067
146,475
Prepaid income taxes
-
-
11,027
9,254
Prepaid expenses and other current assets
31,942
22,087
23,189
18,551
Investment in equity securities
15,626
14,885
9,131
8,859
Total current assets
825,433
747,084
753,117
698,402
Property and equipment, net
73,223
67,115
62,476
63,560
Deferred tax assets, net
71,495
66,555
69,072
71,396
Intangible assets, net
449,857
467,161
479,526
499,817
Goodwill
62,480
62,480
62,480
62,480
Other non-current assets
11,624
11,575
13,706
12,497
Total assets
1,494,112
1,421,970
1,440,377
1,408,152
Accounts payable
73,830
69,694
62,583
69,795
Accrued royalties
55,830
33,926
48,497
51,247
Accrued compensation and related expenses
27,154
16,091
37,897
33,221
Income taxes payable - foreign
-
-
948
-
Accrued government rebates
41,392
38,417
43,154
37,032
Returned goods reserve
44,013
43,052
49,504
50,005
Current contingent consideration
-
-
167
63
Accrued expenses and other
16,575
13,735
16,803
13,951
Income taxes payable
3,532
5,297
1,291
0
Current debt, net
21,329
19,298
17,268
15,241
Total current liabilities
283,655
239,510
278,112
270,555
Debt, net
280,155
285,996
291,840
297,677
Convertible notes, net
309,009
308,466
307,927
307,392
Accrued licensor payments due
-
-
0
4,062
Contingent consideration
8,546
9,248
9,610
11,379
Other non-current liabilities
15,535
16,450
12,164
11,270
Total liabilities
896,900
859,670
899,653
902,335
Common stock, 0.0001 par value, 66,000,000 shares authorized 23,853,338 shares issued and 22,961,423 shares outstanding at june30, 2026 23,112,577 shares issued and 22,491,281 shares outstanding at december31, 2025
3
3
3
3
Treasury stock, 891,915 shares of common stock, at cost, at june30, 2026 and 621,296 shares of common stock, at cost, at december31, 2025
53,817
53,004
33,249
32,638
Additional paid-in capital
620,249
608,429
596,036
586,230
Retained earnings (accumulated deficit)
31,104
6,393
-23,099
-50,589
Accumulated other comprehensive (loss) income, net of tax
-327
479
1,033
2,811
Total stockholders equity
597,212
562,300
540,724
505,817
Total liabilities and stockholders equity
1,494,112
1,421,970
1,440,377
1,408,152
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$360,212K (65.39%↑ Y/Y)Accounts receivable, net$274,469K (21.63%↑ Y/Y)Inventories$143,149K (3.49%↑ Y/Y)Prepaid expenses andother current assets$31,942K (111.40%↑ Y/Y)Investment in equitysecurities$15,626K (173.28%↑ Y/Y)Restricted cash$35K (-2.78%↓ Y/Y)Total current assets$825,433K (36.97%↑ Y/Y)Intangible assets, net$449,857K (-13.54%↓ Y/Y)Property and equipment,net$73,223K (23.59%↑ Y/Y)Deferred tax assets, net$71,495K (-22.31%↓ Y/Y)Goodwill$62,480K (3.22%↑ Y/Y)Other non-currentassets$11,624K (40.97%↑ Y/Y)Total assets$1,494,112K (11.25%↑ Y/Y)Total liabilities andstockholders equity$1,494,112K (11.25%↑ Y/Y)Total liabilities$896,900K (1.76%↑ Y/Y)Total stockholdersequity$597,212K (36.74%↑ Y/Y)Treasury stock, 891,915shares of common stock,...$53,817K (70.34%↑ Y/Y)Accumulated othercomprehensive (loss) income,...-$327K (-109.87%↓ Y/Y)Convertible notes, net$309,009K (0.70%↑ Y/Y)Total currentliabilities$283,655K (19.77%↑ Y/Y)Debt, net$280,155K (-7.07%↓ Y/Y)Other non-currentliabilities$15,535K (132.00%↑ Y/Y)Contingent consideration$8,546K (-52.76%↓ Y/Y)Additional paid-in capital$620,249K (14.46%↑ Y/Y)Retained earnings(accumulated deficit)$31,104K (140.47%↑ Y/Y)Common stock, 0.0001par value,...$3K (50.00%↑ Y/Y)Accounts payable$73,830K (35.30%↑ Y/Y)Accrued royalties$55,830K (54.95%↑ Y/Y)Returned goods reserve$44,013K (-9.59%↓ Y/Y)Accrued governmentrebates$41,392K (25.94%↑ Y/Y)Accrued compensationand related...$27,154K (-17.55%↓ Y/Y)Current debt, net$21,329K (61.39%↑ Y/Y)Accrued expenses andother$16,575K (12.29%↑ Y/Y)Income taxes payable$3,532K (7.23%↑ Y/Y)

ANI PHARMACEUTICALS INC (ANIP)

ANI PHARMACEUTICALS INC (ANIP)